INBX Inhibrx Biosciences, Inc. - Common Stock
$111,50
Fiyat · May 20, 2026
Temel veriler itibarıyla May 14, 2026
52 Haftlık Aralık
$12–$155
69% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$278
+149% upside
P/E (TTM)
-8.7
ROE
-365.9%
Net Kâr Marjı
-10773.5%
INBX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$111.50
Piyasa Değeri
$1.15B
P/E (TTM)
-8.7
EPS (TTM)
$-9.04
Gelir (TTM)
$1M
Temettü Verimi
—
ROE
-365.9%
D/E Borç/Özsermaye
12.6
52 Haftlık Aralık
$12 – $155
INBX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-9.04
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
$-130M
2024-12-31
→
2025-12-31
Marjlar
-10773.5%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
INBX
Akran Ortalaması
P/E (TTM)
-8.7
—
P/S (TTM) (F/S (TTM))
885.9
45.5
P/B (F/D)
144.1
4.8
EV / EBITDA
-8.5
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-8.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
INBX
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-10386.5%
—
Net Profit Margin (Net Kâr Marjı)
-10773.5%
-237.1%
ROA
-85.6%
-41.6%
ROE
-365.9%
-55.3%
ROIC
-124.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
INBX
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
12.6
1.0
Current Ratio (Cari Oran)
3.9
5.7
Quick Ratio (Cari Oran)
3.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
INBX
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
550.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
INBX
Akran Ortalaması
INBX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 3 33,3%
- Al 4 44,4%
- Tut 2 22,2%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
2 analist · 2026-05-18
Medyan
$277.50
← Tüm hedeflerin altında
$111.50
Düşük
$230.00
Yüksek
$325.00
Medyan hedef
$277.50
+148,9%
Ortalama hedef
$277.50
+148,9%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-2.15 | $-1.82 | -0.33% |
| 31 Aralık 2025 | $-2.11 | $-2.12 | 0.01% |
| 30 Eylül 2025 | $-2.28 | $-1.75 | -0.53% |
| 30 Haziran 2025 | $-1.85 | $-2.82 | 0.97% |
| 31 Mart 2025 | $-2.80 | $-2.90 | 0.10% |
| 31 Aralık 2024 | $-3.09 | $-2.94 | -0.15% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1M | $200.0K | $2M | |
| R&D Expense | $113M | $204M | $192M | |
| SG&A Expense | $23M | $128M | $29M | |
| Operating Expenses | $136M | $332M | $221M | |
| Operating Income | $-135M | $-331M | $-219M | |
| Other Non-op | $-381.0K | $75.0K | $-580.0K | |
| Pretax Income | $-140M | $1.69B | $-240M | |
| Income Tax | $2.0K | $2.0K | $3.0K | |
| Net Income | $-140M | $1.69B | $-241M | |
| EPS (Basic) | $-9.04 | $114.01 | $-20.48 | |
| EPS (Diluted) | $-9.04 | $112.62 | $-20.48 | |
| Shares (Basic) | 15,487,000 | 14,802,000 | 11,783,000 | |
| Shares (Diluted) | 15,487,000 | 14,984,000 | 11,783,000 | |
| EBITDA | $-133M | $-329M | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $124M | $153M | $278M | |
| Prepaid Expense | $8M | $7M | $17M | |
| Other Current Assets | $238.0K | $382.0K | $366.0K | |
| Current Assets | $133M | $160M | $295M | |
| PP&E (Net) | $4M | $6M | $6M | |
| PP&E (Gross) | $15M | $15M | $13M | |
| Accum. Depreciation | $11M | $9M | $7M | |
| Other Non-current Assets | $4M | $7M | $3M | |
| Total Assets | $146M | $181M | $308M | |
| Accounts Payable | $6M | $9M | $11M | |
| Accrued Liabilities | $26M | $30M | $43M | |
| Current Liabilities | $34M | $41M | $56M | |
| Capital Leases | $4M | $6M | $1M | |
| Total Liabilities | $138M | $47M | $264M | |
| Total Debt | $101M | $0 | · | |
| Common Stock | $1.0K | $1.0K | $5.0K | |
| Paid-in Capital | $254M | $240M | $657M | |
| Retained Earnings | $-246M | $-106M | $-614M | |
| Stockholders' Equity | $8M | $134M | $44M | |
| Liabilities + Equity | $146M | $181M | $308M | |
| Shares Outstanding | 14,577,609 | 14,476,000 | 47,369,000 |
Nakit Akışı 10
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $1M | |
| Stock-based Comp | $11M | $59M | $25M | |
| Other Non-cash | $-3M | $-1.94B | · | |
| Operating Cash Flow | $-130M | $-194M | $-193M | |
| CapEx | $31.0K | $3M | $5M | |
| Investing Cash Flow | $-28.0K | $-3M | $-5M | |
| Financing Cash Flow | $101M | $72M | $202M | |
| Net Change in Cash | $-28M | $-125M | $4M | |
| Taxes Paid | $2.0K | $2.0K | $3.0K | |
| Free Cash Flow | $-130M | $-197M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -10386.5% | -165724.0% | · | |
| Net Margin | -10773.5% | 843786.0% | · | |
| Pretax Margin | -10773.3% | 843787.0% | · | |
| EBITDA Margin | -10195.5% | -164581.5% | · | |
| ROA | -85.6% | 690.7% | · | |
| ROE | -365.9% | 1081.6% | · | |
| ROIC | -124.4% | -248.1% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.9 | 3.9 | · | |
| Quick Ratio | 3.7 | 3.7 | · | |
| Debt / Equity | 12.6 | 0.0 | · | |
| LT Debt / Equity | 12.6 | 0.0 | · |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 550.0% | -88.9% | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1M | $200.0K | · | |
| Net Income TTM | $-140M | $1.69B | · | |
| Market Cap | $1.15B | $223M | · | |
| Enterprise Value | $1.13B | $70M | · | |
| P/E | -8.7 | 0.1 | · | |
| P/S | 885.9 | 1114.6 | · | |
| P/B | 144.1 | 1.7 | · | |
| P / Tangible Book | 144.1 | 1.7 | · | |
| P / Cash Flow | -8.9 | -1.1 | · | |
| P / FCF | -8.9 | -1.1 | · | |
| EV / EBITDA | -8.5 | -0.2 | · | |
| EV / FCF | -8.7 | -0.4 | · | |
| EV / Revenue | 867.7 | 351.7 | · | |
| Earnings Yield | -11.4% | 731.3% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $1M | $0 | $100.0K | $0 | $100.0K | $0 | $2M | $119.0K | |
| R&D Expense | $25M | $25M | $29M | $22M | $37M | $33M | $39M | $68M | $64M | $82M | $38M | |
| SG&A Expense | $6M | $6M | $5M | $6M | $6M | $17M | $8M | $93M | $10M | $8M | $8M | |
| Operating Expenses | $31M | $31M | $34M | $29M | $43M | $50M | $47M | $161M | $74M | $90M | $46M | |
| Operating Income | $-31M | $-31M | $-34M | $-27M | $-43M | $-50M | $-47M | $-161M | $-74M | $-88M | $-46M | |
| Other Non-op | $-12.0K | $-39.0K | $-46.0K | $-246.0K | $-50.0K | $60.0K | $41.0K | $33.0K | $-59.0K | $-158.0K | $-135.0K | |
| Pretax Income | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-92M | $-52M | |
| Income Tax | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $-4.0K | $2.0K | |
| Net Income | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-94M | $-52M | |
| EPS (Basic) | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.48 | $-2.84 | $127.10 | $-5.77 | $-7.29 | $-4.39 | |
| EPS (Diluted) | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.25 | $-2.84 | $125.48 | $-5.77 | $-7.29 | $-4.39 | |
| Shares (Basic) | 15,585,000 | -30,927,000 | 15,478,000 | 15,468,000 | 15,468,000 | -28,924,000 | 15,468,000 | 14,619,000 | 13,639,000 | 582,000 | 11,788,000 | |
| Shares (Diluted) | 15,585,000 | -30,927,000 | 15,478,000 | 15,468,000 | 15,468,000 | -28,930,000 | 15,468,000 | 14,807,000 | 13,639,000 | 582,000 | 11,788,000 | |
| EBITDA | $-30M | · | $-33M | $-27M | $-42M | · | $-46M | $-160M | · | · | · |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $162M | $124M | $153M | $187M | $217M | $153M | $196M | $227M | · | $278M | · | |
| Prepaid Expense | $9M | $8M | $7M | $6M | $7M | $7M | $10M | $14M | · | $17M | · | |
| Other Current Assets | $262.0K | $238.0K | $410.0K | $283.0K | $269.0K | $382.0K | $748.0K | $966.0K | · | $366.0K | · | |
| Current Assets | $171M | $133M | $161M | $194M | $223M | $160M | $207M | $242M | · | $295M | · | |
| PP&E (Net) | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $8M | · | $6M | · | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $13M | · | |
| Accum. Depreciation | $12M | $11M | $11M | $10M | $10M | $9M | $8M | $7M | · | $7M | · | |
| Other Non-current Assets | $4M | $4M | $6M | $7M | $7M | $7M | $7M | $7M | · | $3M | · | |
| Total Assets | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | |
| Accounts Payable | $9M | $6M | $7M | $8M | $9M | $9M | $12M | $13M | · | $11M | · | |
| Accrued Liabilities | $15M | $26M | $27M | $28M | $33M | $30M | $30M | $24M | · | $43M | · | |
| Current Liabilities | $27M | $34M | $36M | $39M | $44M | $41M | $44M | $39M | · | $56M | · | |
| Capital Leases | $3M | $4M | $5M | $5M | $6M | $6M | $0 | $0 | · | $1M | · | |
| Total Liabilities | $205M | $138M | $141M | $144M | $148M | $47M | $44M | $39M | · | $264M | · | |
| Total Debt | $175M | · | $100M | $99M | $99M | · | $0 | $0 | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | $5.0K | · | |
| Paid-in Capital | $259M | $254M | $250M | $247M | $244M | $240M | $237M | $234M | · | $657M | · | |
| Retained Earnings | $-280M | $-246M | $-213M | $-178M | $-149M | $-106M | $-58M | $-14M | · | $-614M | · | |
| Stockholders' Equity | $-21M | $8M | $37M | $69M | $94M | $134M | $178M | $219M | · | $44M | · | |
| Liabilities + Equity | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | |
| Shares Outstanding | 14,607,286 | 14,577,609 | 14,498,093 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | · | 47,369,511 | · |
Nakit Akışı 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $537.0K | $564.0K | $582.0K | $662.0K | $675.0K | $690.0K | $760.0K | $475.0K | $360.0K | $298.0K | $304.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $46M | $6M | $6M | $7M | |
| Other Non-cash | $-8M | · | · | · | $4M | · | · | · | · | · | · | |
| Operating Cash Flow | $-38M | $-30M | $-34M | $-30M | $-36M | $-44M | $-30M | $-57M | $-63M | $-57M | $-54M | |
| CapEx | $0 | $0 | $10.0K | $0 | $21.0K | $16.0K | $247.0K | $1M | $1M | $3M | $811.0K | |
| Investing Cash Flow | $0 | $0 | $-7.0K | $0 | $-21.0K | $-16.0K | $-247.0K | $-1M | $-1M | $-3M | $-811.0K | |
| Financing Cash Flow | $75M | $1M | $352.0K | $0 | $100M | $0 | $0 | $33M | $39M | $860.0K | $200M | |
| Net Change in Cash | $37M | $-29M | $-33M | $-30M | $64M | $-44M | $-31M | $-26M | $-25M | $-59M | $145M | |
| Taxes Paid | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | · | · | |
| Free Cash Flow | $-38M | · | · | · | $-36M | · | · | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -2106.8% | · | · | · | -160898.0% | · | · | · | |
| Net Margin | · | · | · | -2204.2% | · | · | · | 1858011.0% | · | · | · | |
| Pretax Margin | · | · | · | -2204.0% | · | · | · | 1858013.0% | · | · | · | |
| EBITDA Margin | · | · | · | -2055.9% | · | · | · | -160423.0% | · | · | · | |
| ROA | -15.7% | · | -17.6% | -12.2% | -35.7% | · | -39.4% | 1438.0% | · | · | · | |
| ROE | -91.1% | · | -32.8% | -19.9% | -91.7% | · | -49.2% | 1694.0% | · | · | · | |
| ROIC | -20.1% | · | -24.7% | -16.3% | -22.2% | · | -26.2% | -73.4% | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.5 | · | 4.5 | 5.0 | 5.1 | · | 4.7 | 6.2 | · | · | · | |
| Quick Ratio | 6.1 | · | 4.3 | 4.8 | 5.0 | · | 4.5 | 5.8 | · | · | · | |
| Debt / Equity | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | · | $1M | $1M | $100.0K | · | $219.0K | $249.0K | · | · | · | |
| Net Income TTM | $-141M | · | $-151M | $1.74B | $1.69B | · | $1.68B | $1.68B | · | · | · | |
| Market Cap | $982M | · | $488M | $207M | $203M | · | $227M | $205M | · | · | · | |
| Enterprise Value | $995M | · | $435M | $119M | $85M | · | $30M | $-22M | · | · | · | |
| P/E | -7.4 | · | -3.4 | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | |
| P/S | 755.4 | · | 375.6 | 147.6 | 2025.2 | · | 1035.1 | 823.8 | · | · | · | |
| P/B | -46.7 | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | |
| P / Tangible Book | · | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | |
| P / Cash Flow | -25.8 | · | · | · | -5.6 | · | · | · | · | · | · | |
| P / FCF | -25.8 | · | · | · | -5.6 | · | · | · | · | · | · | |
| EV / EBITDA | -32.8 | · | -13.1 | -4.5 | -2.0 | · | -0.7 | 0.1 | · | · | · | |
| EV / FCF | -26.2 | · | · | · | -2.4 | · | · | · | · | · | · | |
| EV / Revenue | 765.7 | · | 334.7 | 85.2 | 846.5 | · | 138.6 | -87.3 | · | · | · | |
| Earnings Yield | -13.5% | · | -29.0% | 826.8% | 815.4% | · | 718.3% | 783.4% | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Gelir | $1M | $200.0K | $2M |
| Faaliyet Kâr Marjı % | -10386.5% | -165724.0% | — |
| Net Gelir | $-140M | $1.69B | $-241M |
| Seyreltilmiş Hisse Başı Kâr | $-9.04 | $112.62 | $-20.48 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Borç / Öz Sermaye | 12.6 | 0.0 | — |
| Cari Oran | 3.9 | 3.9 | — |
| Cari Oran | 3.7 | 3.7 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Serbest Nakit Akışı | $-130M | $-197M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.